Cerebrospinal Fluid τ Protein in Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia in Chinese population
Authors:
- 27 October 2013
- journal article
- research article
- Published by SAGE Publications in American Journal of Alzheimer's Disease and Other Dementias®
- Vol. 29 (2) , 116-122
Abstract
Background: To assess whether biomarker τ protein could differentiate between Alzheimer’s disease (AD) and vascular dementia (VaD). Methods: We conducted a comprehensive search to identify studies on τ protein, patients with AD, and patients with VaD. Cerebrospinal fluid (CSF) τ protein levels were compared to discriminate among patients with AD, healthy controls, and patients with VaD by a meta-analysis. Results: Patients with AD exhibit significantly higher CSF τ protein levels than healthy controls or patients with VaD in the Chinese population. Conclusion: Our findings suggested that CSF τ protein levels were found to be significantly associated with AD in the Chinese population. Measurement of τ protein could help in attenuating the strict distinction between AD and VaD.Keywords
This publication has 41 references indexed in Scilit:
- Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s DiseaseBiomarkers in Medicine, 2012
- Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up StudyPLOS ONE, 2012
- Biomarkører i spinalvæske ved demensTidsskrift for Den norske legeforening, 2011
- Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised QstatisticsBMC Medical Research Methodology, 2011
- CSF biomarker profile and diagnostic value in vascular dementiaEuropean Journal of Neurology, 2009
- Adiposity, hyperinsulinemia, diabetes and Alzheimer's diseaseEuropean Journal of Pharmacology, 2008
- Uncertainty in heterogeneity estimates in meta-analysesBMJ, 2007
- Vascular oxidative stress in Alzheimer diseaseJournal of the Neurological Sciences, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003